Cardiovascular Benefits of Native GLP-1 and Its Metabolites: An Indicator for GLP-1-Therapy Strategies

Frontiers in Physiology- Switzerland

doi 10.3389/fphys.2017.00015

Full Text

Abstract

Available in

Categories

Physiology

Date

Authors

Publisher

Frontiers Media SA

Related search

The Cardiovascular Effects of GLP-1 Receptor Agonists

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2010English

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Glucagon, GLP-1 and Thermogenesis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

GLP 1 and Macrovascular Complications

Journal of Diabetes & Metabolism
2011English

GLP-1 and the Gut

Gut
Gastroenterology
2000English

Gefäßschutz Durch GLP-1-Agonisten?

Info Diabetologie
2010German

Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 (GLP-1) Gene Therapy for Diabetes

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2018English

Emerging Technologies to Achieve Oral Delivery of GLP-1 and GLP-1 Analogs for Treatment of Type 2 Diabetes Mellitus (T2DM)

Canadian Journal of Biotechnology
2017English

Extra Glycemic Impacts of GLP-1 Receptor Agonists: Benefits of a Class Effect?

Open Journal of Endocrine and Metabolic Diseases
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy